Alignment Healthcare, Inc. (ALHC)
NASDAQ (NGS) NASDAQ (NGS) Primary 
Alignment Healthcare (ALHC) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Alignment Healthcare (ALHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Alignment Healthcare (ALHC) Moves 12.7% Higher: Will This Strength Last?
Alignment Healthcare (ALHC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Alignment Healthcare, Inc. (ALHC) Q2 2024 Earnings Call Transcript
Alignment Healthcare, Inc. (NASDAQ:ALHC ) Q2 2024 Earnings Conference Call August 1, 2024 5:30 PM ET Company Participants John Kao - Founder & Chief Executive Officer Thomas Freeman - Chief Financial Officer Conference Call Participants John Ransom - Raymond James Whit Mayo - Leerink Partners Michael Ha - Baird Jess Tassan - Piper Sandler Jared Haase - William Blair Adam Ron - Bank of America Scott Fidel - Stephens Ryan Langston - TD Cowen Andrew Mok - Barclays Operator Good afternoon and welcome to Alignment Healthcare's Second Quarter 2024 Earnings Conference Call and Webcast. All participants will be in a listen-only mode.
Alignment Healthcare (ALHC) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
While the top- and bottom-line numbers for Alignment Healthcare (ALHC) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Alignment Healthcare (ALHC) Reports Q2 Loss, Tops Revenue Estimates
Alignment Healthcare (ALHC) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to loss of $0.15 per share a year ago.
Alignment Healthcare (ALHC) Surges 11.5%: Is This an Indication of Further Gains?
Alignment Healthcare (ALHC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Panagora Asset Management Inc. Cuts Stake in Alignment Healthcare, Inc. (NASDAQ:ALHC)
Panagora Asset Management Inc. decreased its position in Alignment Healthcare, Inc. (NASDAQ:ALHC – Free Report) by 0.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 342,804 shares of the company’s stock after selling 2,994 shares during the period. Panagora Asset Management Inc. owned about 0.18% of Alignment Healthcare worth $2,952,000 at the end of the most recent quarter. Other institutional investors and hedge funds have also made changes to their positions in the company. Barlow Wealth Partners Inc. purchased a new stake in Alignment Healthcare in the 4th quarter valued at approximately $100,000. Teza Capital Management LLC purchased a new stake in shares of Alignment Healthcare in the third quarter valued at approximately $109,000. Victory Capital Management Inc. grew its holdings in Alignment Healthcare by 17.9% during the fourth quarter. Victory Capital Management Inc. now owns 12,935 shares of the company’s stock worth $111,000 after acquiring an additional 1,962 shares during the period. Aigen Investment Management LP acquired a new position in Alignment Healthcare during the third quarter worth $116,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank raised its position in Alignment Healthcare by 75.5% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 26,427 shares of the company’s stock worth $183,000 after acquiring an additional 11,370 shares in the last quarter. 86.19% of the stock is currently owned by institutional investors and hedge funds. Insider Buying and Selling In other news, CEO John E. Kao bought 103,000 shares of Alignment Healthcare stock in a transaction that occurred on Thursday, March 14th. The shares were purchased at an average price of $4.82 per share, for a total transaction of $496,460.00. Following the completion of the acquisition, the chief executive officer now owns 2,745,253 shares of the company’s stock, valued at $13,232,119.46. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other Alignment Healthcare news, CEO John E. Kao purchased 103,000 shares of the business’s stock in a transaction that occurred on Thursday, March 14th. The shares were purchased at an average price of $4.82 per share, for a total transaction of $496,460.00. Following the completion of the acquisition, the chief executive officer now owns 2,745,253 shares of the company’s stock, valued at approximately $13,232,119.46. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Robert Thomas Freeman sold 11,858 shares of Alignment Healthcare stock in a transaction that occurred on Friday, March 15th. The shares were sold at an average price of $4.89, for a total transaction of $57,985.62. Following the transaction, the chief financial officer now directly owns 898,228 shares in the company, valued at $4,392,334.92. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 90,213 shares of company stock valued at $460,587. 6.30% of the stock is currently owned by company insiders. Analysts Set New Price Targets A number of equities analysts have recently weighed in on ALHC shares. Stifel Nicolaus lowered their price target on shares of Alignment Healthcare from $11.00 to $9.00 and set a “buy” rating on the stock in a research note on Tuesday, April 23rd. Stephens increased their target price on shares of Alignment Healthcare from $6.00 to $7.00 and gave the company an “equal weight” rating in a report on Friday, May 3rd. Barclays assumed coverage on Alignment Healthcare in a research note on Wednesday, March 6th. They set an “underweight” rating and a $4.50 price target on the stock. William Blair reaffirmed an “outperform” rating on shares of Alignment Healthcare in a research note on Wednesday, March 6th. Finally, Piper Sandler upgraded Alignment Healthcare from a “neutral” rating to an “overweight” rating and boosted their target price for the stock from $6.00 to $8.00 in a research report on Wednesday, May 8th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating, four have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, Alignment Healthcare presently has a consensus rating of “Moderate Buy” and an average price target of $8.69. Get Our Latest Stock Report on Alignment Healthcare Alignment Healthcare Trading Up 3.9 % Shares of ALHC opened at $7.26 on Monday. The company has a market capitalization of $1.39 billion, a PE ratio of -8.64 and a beta of 1.23. The company has a debt-to-equity ratio of 1.23, a quick ratio of 1.57 and a current ratio of 1.57. Alignment Healthcare, Inc. has a fifty-two week low of $4.46 and a fifty-two week high of $9.20. The stock has a fifty day moving average of $5.36 and a two-hundred day moving average of $6.52. Alignment Healthcare (NASDAQ:ALHC – Get Free Report) last released its earnings results on Thursday, May 2nd. The company reported ($0.25) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.24) by ($0.01). The company had revenue of $628.60 million during the quarter, compared to analyst estimates of $599.75 million. Alignment Healthcare had a negative return on equity of 91.06% and a negative net margin of 7.81%. Alignment Healthcare’s revenue was up 43.1% on a year-over-year basis. During the same period in the prior year, the business posted ($0.20) earnings per share. As a group, analysts forecast that Alignment Healthcare, Inc. will post -0.64 EPS for the current year. Alignment Healthcare Company Profile (Free Report) Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California. See Also Five stocks we like better than Alignment Healthcare How to Read Stock Charts for Beginners JD’s Earnings Could Mean Chinese Stocks Making a Comeback Best Stocks Under $10.00 Canada Goose Flies Higher Driven By DTC Growth Investing in large cap stocks: Diving into big caps CVS Health Stock Has a Silver Lining Called Value Want to see what other hedge funds are holding ALHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Alignment Healthcare, Inc. (NASDAQ:ALHC – Free Report).
